dutasteride accord 0.5 mg kapseli, pehmeä
accord healthcare b.v. accord healthcare b.v. - dutasteridum - kapseli, pehmeä - 0.5 mg - dutasteridi
clarithromycin accord 250 mg tabletti, kalvopäällysteinen
accord healthcare b.v. accord healthcare b.v. - clarithromycinum - tabletti, kalvopäällysteinen - 250 mg - klaritromysiini
clarithromycin accord 500 mg tabletti, kalvopäällysteinen
accord healthcare b.v. accord healthcare b.v. - clarithromycinum - tabletti, kalvopäällysteinen - 500 mg - klaritromysiini
diazepam accord 5 mg tabletti
accord healthcare b.v. accord healthcare b.v. - diazepamum - tabletti - 5 mg - diatsepaami
diazepam accord 10 mg tabletti
accord healthcare b.v. accord healthcare b.v. - diazepamum - tabletti - 10 mg - diatsepaami
bivalirudin accord 250 mg kuiva-aine välikonsentraatiksi injektio-/infuusionestettä varten, liuos
accord healthcare b.v. accord healthcare b.v. - bivalirudinum - kuiva-aine välikonsentraatiksi injektio-/infuusionestettä varten, liuos - 250 mg - bivalirudiini
tolterodine accord 2 mg depotkapseli, kova
accord healthcare b.v. accord healthcare b.v. - tolterodini tartras - depotkapseli, kova - 2 mg - tolterodiini
tolterodine accord 4 mg depotkapseli, kova
accord healthcare b.v. accord healthcare b.v. - tolterodini tartras - depotkapseli, kova - 4 mg - tolterodiini
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
sildenafil accord 50 mg tabletti, kalvopäällysteinen
accord healthcare b.v. accord healthcare b.v. - sildenafili citras - tabletti, kalvopäällysteinen - 50 mg - sildenafiili